Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Letters|December 15, 2004
Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patientsApril N Tucker, Katherine A Tkaczuk, Lynn M Lewis, et al.
Biology of Reproduction|March 3, 2007
The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsivenessKimberly R Barnett, Dragana Tomic, Rupesh K Gupta, et al.
Biomolecules & Biomedicine|October 10, 2024
Correlation between blood cell indices and adiponectin and leptin levels in COVID-19Mia Manojlovic, Branislava Ilincic, Marko Bojovic, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 3, 2006
Effects of ERalpha overexpression on female reproduction in miceDragana Tomic, Maria Silvina Frech, Janice K Babus, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 22, 2006
Methoxychlor induces atresia of antral follicles in ERalpha-overexpressing miceDragana Tomic, Maria Silvina Frech, Janice K Babus, et al.
Toxicology and Applied Pharmacology|June 28, 2007
The aryl hydrocarbon receptor is required for normal gonadotropin responsiveness in the mouse ovaryKimberly R Barnett, Dragana Tomic, Rupesh K Gupta, et al.
Angiology|July 24, 2014
Vitamin D and Dysfunctional Adipose Tissue in ObesityEdita Stokić, Aleksandar Kupusinac, Dragana Tomic-Naglic, et al.
Current Vascular Pharmacology|February 4, 2017
Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in ObesityDjordje S Popovic, Edita Stokic, Milena Mitrovic, et al.
Current Neurovascular Research|June 20, 2017
The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in ObesityDjordje S Popovic, Milena Mitrovic, Dragana Tomic-Naglic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
Pageof 2